Complete healing of EE | Difference (%) from HGP1705 40 mg | 95% CI on the difference | P-value* | |
---|---|---|---|---|
PPS by week 8 | ||||
HIP1601 (n = 93) | 91 (97.8%) | 1.0 | -4.7, 7.2 | < 0.001 |
HGP1705 (n = 94) | 91 (96.8%) | |||
FAS by week 8 | ||||
HIP1601 (n = 103) | 101 (98.1%) | 3.1 | -2.5, 9.7 | < 0.001 |
HGP1705 (n = 100) | 95 (95.0%) | |||
PPS at week 4 | ||||
HIP1601 (n = 93) | 85 (91.4%) | -1.2 | -8.9, 6.6 | 0.013 |
HGP1705 (n = 94) | 87 (92.6%) | |||
FAS at week 4 | ||||
HIP1601 (n = 103) | 95 (92.2%) | 3.2 | -4.8, 11.3 | 0.001 |
HGP1705 (n = 100) | 89 (89.0%) |